Cargando…

Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer

BACKGROUND: High expression of L1 cell adhesion molecules (L1CAM) has been repeatedly shown to be associated with aggressive disease behavior, which translates in poor clinical outcome in various cancer entities. However, in ovarian cancer results based either on immunohistochemistry or cytosolic pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azim, Samira Abdel, Duggan-Peer, Michaela, Sprung, Susanne, Reimer, Daniel, Fiegl, Heidi, Soleiman, Afschin, Marth, Christian, Zeimet, Alain G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095069/ https://www.ncbi.nlm.nih.gov/pubmed/27174921 http://dx.doi.org/10.18632/oncotarget.9291

Ejemplares similares

Evaluating L1CAM expression in human endometrial cancer using qRT-PCR
por: Notaro, Sara, et al.
Publicado: (2016)

Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer
por: Schmid, Gabriel, et al.
Publicado: (2016)

High RIG‐I expression in ovarian cancer associates with an immune‐escape signature and poor clinical outcome
por: Wolf, Dominik, et al.
Publicado: (2019)

Clinical Impact of RANK Signalling in Ovarian Cancer
por: Wieser, Verena, et al.
Publicado: (2019)

Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer
por: Leitner, Katharina, et al.
Publicado: (2020)

BRCA1/2 and TP53 mutation status associates with PD-1 and PD-L1 expression in ovarian cancer
por: Wieser, Verena, et al.
Publicado: (2018)

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers
por: Notaro, Sara, et al.
Publicado: (2016)

BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancer
por: Tsibulak, Irina, et al.
Publicado: (2018)

The miR-34 family and its clinical significance in ovarian cancer
por: Welponer, Hannah, et al.
Publicado: (2020)

Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2013)

Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2018)

A comparison of four technologies for detecting p53 aggregates in ovarian cancer
por: Heinzl, Nicole, et al.
Publicado: (2022)

Evaluation of Vav3.1 as prognostic marker in endometrial cancer
por: Boesch, Maximilian, et al.
Publicado: (2018)

Detection of soluble EpCAM (sEpCAM) in malignant ascites predicts poor overall survival in patients treated with catumaxomab
por: Seeber, Andreas, et al.
Publicado: (2015)

Role of miR-34a as a suppressor of L1CAM in endometrial carcinoma
por: Schirmer, Uwe, et al.
Publicado: (2014)

Tumor necrosis factor receptor modulator spermatogenesis‐associated protein 2 is a novel predictor of outcome in ovarian cancer
por: Wieser, Verena, et al.
Publicado: (2019)

Endometroid carcinoma developing in endometriosis over the symphysis pubis()
por: Peer, Michaela, et al.
Publicado: (2013)

Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer
por: Luger, Anna K., et al.
Publicado: (2020)

Influence of Pregnancy-Related Conditions on Human Epididymis Protein 4 Serum Levels in Comparison to CA 125 – a Prospective Cohort Trial
por: Azim, Samira Abdel, et al.
Publicado: (2021)

Efficacy of an optimal ovarian cancer screening: a best-case scenario study based on real-world data
por: Steinkasserer, Lena, et al.
Publicado: (2021)

AGO Austria recommendations for genetic testing of patients with ovarian cancer
por: Marth, Christian, et al.
Publicado: (2015)

L1CAM is expressed in triple-negative breast cancers and is inversely correlated with Androgen receptor
por: Doberstein, Kai, et al.
Publicado: (2014)

Fatal invasive cervical cancer secondary to untreated cervical dysplasia: a case report
por: Braun, Stephan, et al.
Publicado: (2011)

High prevalence of side population in human cancer cell lines
por: Boesch, Maximilian, et al.
Publicado: (2016)

The sL1CAM in sera of patients with endometrial and ovarian cancers
por: Wojciechowski, Michał, et al.
Publicado: (2016)

High serum levels of soluble CD44 variant isoform v5 are associated with favourable clinical outcome in ovarian cancer.
por: Zeimet, A. G., et al.
Publicado: (1997)

The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics
por: Boesch, Maximilian, et al.
Publicado: (2014)

Cisplatin resistance is associated with reduced interferon-gamma-sensitivity and increased HER-2 expression in cultured ovarian carcinoma cells.
por: Marth, C., et al.
Publicado: (1997)

Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy
por: Dold, Catherine, et al.
Publicado: (2016)

Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance
por: Brennan, Donal J, et al.
Publicado: (2015)

Successful Treatment of Focal Segmental Glomerulosclerosis after Kidney Transplantation with Plasma Exchange and Abatacept in a Patient with Juvenile Rheumatoid Arthritis
por: Sprenger-Mähr, Hannelore, et al.
Publicado: (2016)

Onchocerca jakutensis Filariasis in Humans
por: Koehsler, Martina, et al.
Publicado: (2007)

AGO Austria recommendation on screening and diagnosis of Lynch syndrome (LS)
por: Zeimet, Alain G., et al.
Publicado: (2017)

Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study
por: Brunner, Christine, et al.
Publicado: (2022)

Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance
por: Chakravarthy, Ankur, et al.
Publicado: (2022)

Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium
por: Ray-Coquard, Isabelle, et al.
Publicado: (2019)

Intraductal tubulopapillary neoplasm (ITPN) of the pancreas associated with an invasive component: a case report with review of the literature
por: Kuscher, Stefanie, et al.
Publicado: (2017)

Forty‐eight hours of normothermic kidney preservation applying urine recirculation
por: Weissenbacher, Annemarie, et al.
Publicado: (2022)

48 h Normothermic Machine Perfusion With Urine Recirculation for Discarded Human Kidney Grafts
por: Messner, Franka, et al.
Publicado: (2023)

Development of chimeric antigen receptor-redirected T cell therapy targeting L1-CAM in ovarian cancer
por: Hong, Hao, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ek203a7lpgkjdg54f9g5c2mo9s